Sustained release formulations

Details Sustained release formulations Sustained release formulations

2008-01-29

2008-01-29

Russel, Jeffrey Edwin (Department: 1654)

Drug, bio-affecting and body treating compositions

Immunoglobulin, antiserum, antibody, or antibody fragment,...

C514S002600, C514S015800, C514S785000

Reexamination Certificate

active

07323169

ABSTRACT:
The present invention relates broadly to the field of sustained release formulations. More specifically, the invention describes compositions and methods relating to formulating proteins and/or peptides with purified gallic acid esters. In one example, the gallic acid ester is PentaGalloylGlucose (PGG) and in anther example the gallic acid ester is epigallocatechin gallate (EGCG).

REFERENCES:
patent: 5019400 (1991-05-01), Gombotz et al.
patent: 5192741 (1993-03-01), Orsolini et al.
patent: 5916597 (1999-06-01), Lee et al.
patent: 5922253 (1999-07-01), Herbert et al.
patent: 5962522 (1999-10-01), Wacher et al.
patent: 5981474 (1999-11-01), Manning et al.
patent: 6180666 (2001-01-01), Wacher et al.
patent: 6428818 (2002-08-01), Morre et al.
patent: 6531154 (2003-03-01), Mathiowitz et al.
patent: 6613358 (2003-09-01), Randolph et al.
patent: 6759064 (2004-07-01), Morre et al.
patent: 2002/0119946 (2002-08-01), Gen
patent: 2002/0151582 (2002-10-01), Dou et al.
patent: 2004/0142048 (2004-07-01), Morre et al.
patent: 2005/0215470 (2005-09-01), Ng et al.
patent: 929405 (1963-06-01), None
patent: 1234805 (1971-06-01), None
patent: WO 94/08599 (1994-04-01), None
patent: WO 98/10649 (1998-03-01), None
patent: WO 99/04764 (1999-02-01), None
patent: WO 00/51643 (2000-09-01), None
patent: WO 01/32218 (2001-05-01), None
patent: WO2004012522 (2004-02-01), None
Hatano et al. Size exclusionn chromatographic analysis of polyphenol-serum albumin complexes. Phytochemistry. 2003, vol. 63, pp. 817-823.
Naurato et al. Interaction of Tannin with Human Salivary Histatins. Journal of Agricultural and Food Chemistry. May, 4, 1999, vol. 47, No. 6, pp. 2229-2234.
M. Chasin, “Biodegradable Polymers for Controlled Drug Delivery” J.O. Hollinger Editor,Biomedical Applications of Synthetic Biodegradable PolymersCRC, Boca Raton, Florida (1995) pp. 1-15.
T. Hayashi, “Biodegradable Polympers for Biomedical Uses”Prog. Polym. Sci. 19:4 (1994) pp. 663-700.
Harjit Tamber et al, “Formulation Aspects of Biodegradable Polymeric Microspheres for Antigen Delivery”Advanced Drug Delivery Reviews, 57:3 (2005) pp. 35i-376.
Zhang, Y.-J. et al., “Association of Tannins and Related Polyphenols with Cyclic Peptide Gramicidin S,”Chem. Pharm. Bull., 50(2), pp. 258-262 (2002); published by Pharmaceutical Society of Japan.
Matsuo, A. et al., “Interaction of Peptides Having a Turn Structure with Tannins,”Peptide Science 2001, pp. 205-206, H. Aoyagi (Ed.); The Japanese Peptide Society (2002).
Charlton, A. J. et al., “Polyphenol/Peptide Binding and Precipitation,”J. Agric. Food Chem., 50, pp. 1593-1601 (2002); published by American Chemical Society.

Affiliated with

Also associated with

Rating

Sustained release formulations does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Sustained release formulations, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sustained release formulations will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2794902